Article
Exosome-derived lncRNA HOXA-AS3 promotes castration resistance and progression of prostate…
medRxiv · 2022 · Jie, T.; Cai, Q.; Zhao, Y.; Shang, L.; Li, Y.; Zhang, J.; Zhu, L.; Chen, Y.; Li, G.; Liu, Z.; Jia, M.; Kang, S.; Niu, H.; Niu, Y.
Key facts
| Title | Exosome-derived lncRNA HOXA-AS3 promotes castration resistance and progression of prostate cancer via the miR-29b-3p/Mcl-1/STAT3 axis |
|---|---|
| First author | Jie, T.; Cai, Q.; Zhao, Y.; Shang, L.; Li, Y.; Zhang, J.; Zhu, L.; Chen, Y.; Li, G.; Liu, Z.; Jia, M.; Kang, S.; Niu, H.; Niu, Y. |
| Journal | medRxiv |
| Published | Sep 29, 2022 |
| DOI | 10.1101/2022.09.28.509879 |
| Devices mentioned | DEN000008, K022086, K973350, K990827 |
| Product codes mentioned | JCI, KIT, NDS, JLX, KQP |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1